Comment
doi: 10.1016/S0140-6736(24)00053-9.
Epub 2024 Feb 22.
First Africa-based clinical trial for novel type 2 oral poliovirus vaccine
Affiliations
- PMID: 38402883
- DOI: 10.1016/S0140-6736(24)00053-9
Item in Clipboard
Comment
First Africa-based clinical trial for novel type 2 oral poliovirus vaccine
Lancet.
.
No abstract available
Conflict of interest statement
We declare no competing interests.
Comment on
-
Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial.Lancet. 2024 Mar 23;403(10432):1164-1175. doi: 10.1016/S0140-6736(23)02844-1. Epub 2024 Feb 22. Lancet. 2024. PMID: 38402887 Free PMC article. Clinical Trial.
Similar articles
-
[Possible method of eradication of poliomyelitis as an infection].Zh Mikrobiol Epidemiol Immunobiol. 2012 May-Jun;(3):107-13. Zh Mikrobiol Epidemiol Immunobiol. 2012. PMID: 22830285 Review. Russian.
-
Randomized trial of type 1 and type 3 oral monovalent poliovirus vaccines in newborns in Africa.J Infect Dis. 2012 Jan 15;205(2):228-36. doi: 10.1093/infdis/jir721. Epub 2011 Dec 8. J Infect Dis. 2012. PMID: 22158680 Clinical Trial.
-
Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: A randomized controlled non-inferiority clinical trial.Hum Vaccin Immunother. 2017 Jun 3;13(6):1-10. doi: 10.1080/21645515.2017.1288769. Epub 2017 Mar 1. Hum Vaccin Immunother. 2017. PMID: 28362135 Free PMC article. Clinical Trial.
-
Monovalent type 1 oral poliovirus vaccine in newborns.N Engl J Med. 2008 Oct 16;359(16):1655-65. doi: 10.1056/NEJMoa0800390. N Engl J Med. 2008. PMID: 18923170 Clinical Trial.
-
Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strains.Expert Rev Vaccines. 2011 May;10(5):635-44. doi: 10.1586/erv.11.51. Expert Rev Vaccines. 2011. PMID: 21604984 Review.
Cited by
-
Global Impact of Mass Vaccination Campaigns on Circulating Type 2 Vaccine-Derived Poliovirus Outbreaks: An Interrupted Time-Series Analysis.J Infect Dis. 2025 Feb 20;231(2):e446-e455. doi: 10.1093/infdis/jiae614. J Infect Dis. 2025. PMID: 39873524 Free PMC article.
-
Review of Poliovirus Transmission and Economic Modeling to Support Global Polio Eradication: 2020-2024.Pathogens. 2024 May 22;13(6):435. doi: 10.3390/pathogens13060435. Pathogens. 2024. PMID: 38921733 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
